Viridian Therapeutics, Inc.
Clinical trials sponsored by Viridian Therapeutics, Inc., explained in plain language.
-
New injection treatment tested for bulging eyes condition
Disease control OngoingThis study is testing whether VRDN-003 injections are safe and how the body processes the drug in people with thyroid eye disease. Participants receive injections every 4 or 8 weeks and researchers monitor for side effects. The trial includes 87 adults with thyroid eye disease wh…
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New injection shows promise for bulging eyes condition
Disease control OngoingThis study is testing whether regular injections of an experimental drug called VRDN-003 can help people with active Thyroid Eye Disease. About 117 participants will receive either the drug or a placebo injection every 4 or 8 weeks to see if it reduces eye bulging, inflammation, …
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New eye injection trial aims to control debilitating thyroid eye condition
Disease control OngoingThis study is testing whether regular injections of an investigational drug called VRDN-003 can help control chronic Thyroid Eye Disease. About 195 participants with moderate to severe symptoms will receive either the drug or a placebo injection every 4 or 8 weeks. Researchers wi…
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New injection treatment tested for bulging eyes condition
Disease control OngoingThis study is testing whether VRDN-003 injections are safe and tolerable for people with Thyroid Eye Disease (TED), which causes eye bulging and discomfort. The trial involves 321 participants who receive injections every 4 or 8 weeks for 24 weeks. Researchers are measuring side …
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC